LabCorp inks a testing deal; AstraZeneca moves away from contract manufacturing;

> LabCorp ($LH), owner of Covance, signed a deal with regenerative medicine outfit ORIG3N to handle clinical storage and testing. More

> AstraZeneca ($AZN) is bringing more of its biologics manufacturing in-house, laying out $285 million for a new plant in Sweden. Story